Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program

Haematologica

Volumn 93, Issue 11, 2008, Pages 1686-1693

  Kimura, Fumihiko ^a   Sato, Ken ^a   Kobayashi, Shinichi ^a   Ikeda, Takashi ^a,b   Sao, Hiroshi ^c   Okamoto, Shinichiro ^d   Miyamura, Koichi ^e   Mori, Shin Ichiro ^f   Akiyama, Hideki ^g   Hirokawa, Makoto ^h   Ohto, Hitoshi ⁱ   Ashida, Hiroshi ^a   Motoyoshi, Kazuo ^a,j  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b SHIZUOKA CANCER CENTER   (Japan)

^c Meitetsu Hospital   (Japan)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^f NATIONAL CANCER CENTER HOSPITAL   (Japan)

^g TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^h Medical Committee   (Japan)

ⁱ Japan Marrow Donor Program   (Japan)

^j NONE   (Japan)

more..

Author keywords

AB0 blood type; Acute graft vs host disease; Bone marrow transplantation; Graft failure; Unrelated donor

Indexed keywords

ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; BONE MARROW TRANSPLANTATION; ENGRAFTMENT; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HUMAN; MORTALITY; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGED; ANTILYMPHOCYTE SERUM; BLOOD GROUP INCOMPATIBILITY; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; INFANT; JAPAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 55549103689     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12933     Document Type: Article

References (22)

1. Rydberg L. ABO-incompatibility in solid organ transplantation. Transfus Med 2001;11:325-42.
2. Mielcarek M, Leisenring W, Torok-Storb B, Storb R. Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect. Blood 2000;96:1150-6.
3. Stussi G, Seebach L, Muntwyler J, Schanz U, Gmur J, Seebach JD. Graft-versus-host disease and survival after ABO-incompatible allogeneic bone marrow transplantation: a single-centre experience. Br J Haematol 2001;113:251-3.
4. Stussi G, Muntwyler J, Passweg JR, Seebach L, Schanz U, Gmur J, et al. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2002;30:87-93.
5. Erker CG, Steins MB, Fischer RJ, Kienast J, Berdel WE, Sibrowski W, et al. The influence of blood group differences in allogeneic hematopoietic peripheral blood progenitor cell transplantation. Transfusion 2005;45:1382-90.
6. Seebach JD, Stussi G, Passweg JR, Loberiza FR Jr, Gajewski JL, Keating A, et al. ABO blood group barrier in allogeneic bone marrow transplantation revisited. Biol Blood Marrow Transplant 2005;11:1006-13.
7. Rozman P, Kosir A, Bohinjec M. Is the ABO incompatibility a risk factor in bone marrow transplantation? Transpl Immunol 2005;14:159-69.
8. Canals C, Muniz-Diaz E, Martinez C, Martino R, Moreno I, Ramos A, et al. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning. Transfusion 2004;44:1603-11.
9. Kim JG, Sohn SK, Kim DH, Baek JH, Lee KB, Min WS, et al. Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2005;35:489-95.
10. Bolan CD, Leitman SF, Griffith LM, Wesley RA, Procter JL, Stroncek DF, et al. Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood 2001;98:1687-94.
11. Peggs KS, Morris EC, Kottaridis PD, Geary J, Goldstone AH, Linch DC, et al. Outcome of major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation may be influenced by conditioning regimen. Blood 2002;99:4642-3.
12. Kanda Y, Tanosaki R, Nakai K, Saito T, Ohnishi M, Niiya H, et al. Impact of stem cell source and conditioning regimen on erythrocyte recovery kinetics after allogeneic haematopoietic stem cell transplantation from an ABO-incompatible donor. Br J Haematol 2002;118:128-31.
13. Resnick IB, Tsirigotis PD, Shapira MY, Aker M, Bitan M, Samuel S, et al. ABO incompatibility is associated with increased non-relapse and GVHD related mortality in patients with malignancies treated with a reduced intensity regimen: a single center experience of 221 patients. Biol Blood Marrow Transplant 2008;14:409-17.
14. Worel N, Greinix HT, Schneider B, Kurz M, Rabitsch W, Knobl P, et al. Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems. Transfusion 2000;40:543-50.
15. Rabitsch W, Knobl P, Prinz E, Keil F, Greinix H, Kalhs P, et al. Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption. Bone Marrow Transplant 2003;32:1015-9.
16. Cooling LLW, Kelly K, Barton J, Hwang D, Koerner TAW, Olson JD. Determinants of ABH expression on human blood platelets. Blood 2005;105:3356-64.
17. Dunstan RA. Status of major red cell blood group antigens on neutrophils, lymphocytes and monocytes. Br J Haematol 1986;62:301-9.
18. Remberger M, Watz E, Ringden O, Mattsson J, Shanwell A, Wikman A. Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007;13:675-82.
19. Oh H, Loberiza FR Jr, Zhang MJ, Ringden O, Akiyama H, Asai T, et al. Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations. Blood 2005;10:1408-16.
20. Ernst C, Thurin J, Atkinson B, Wurzel H, Herlyn M, Stromberg N, et al. Monoclonal antibody localization of A and B isoantigens in normal and malignant fixed human tissues. Am J Pathol 1984;117:451-61.
21. Nakanuma Y, Sasaki M. Expression of blood group-related antigens in the intrahepatic biliary tree and hepatocytes in normal livers and various hepatobiliary diseases. Hepatology 1989;10:174-8.
22. Sanchez-Urdazpal L, Batts KP, Gores GJ, Moore SB, Sterioff S, Wiesner RH, et al. Increased bile duct complications in liver transplantation across the ABO barrier. Ann Surg 1993;218:152-8.